We propose replacing an existing FACSVantage SE cell sorter at the University of Utah's Health Sciences Center with a four laser (405, 488, 561 and 640 nm) FACSAria-II SORP cell sorter. The existing instrument was purchased in 1994 with NCRR funding and, despite institutionally funded upgrades, no longer meets the needs of investigators. The Vantage is limited to 6-color sorting but, lacking cross beam compensation, effective resolution of some fluorochromes is diminished by spill over making 6 colors technically impractical. The Vantage can only do two-way sorting, sample processing is relatively slow (4K-10K cells/sec depending on sample) and the increasingly common red fluorescent proteins (ex. m-Cherry) cannot be used. Currently, investigators are running 6-8 color analyses on newer flow cytometric analyzers on campus which cannot be replicated on the Vantage for cell sorting. Many investigators, dealing with limited sample material, want to sort three or four subpopulations which necessitate two sequential runs on the Vantage resulting in loss of some of the limited sample and increased time. Investigators using red fluorescent proteins as reporters are completely unable to sort cells on which they have already gathered imaging data using these probes. And finally, the manufacturer will no longer support the Vantage after 2010 making service and replacement parts problematic. The Vantage is located in a core lab and is the only shared use cell sorter on campus serving the Medical Center, Huntsman Cancer Institute, Eccles Genetics Institute, Howard Hughes Medical Institute, School of Pharmacy and undergraduate departments. A wide variety of sample material is analyzed and sorted ranging from bacteria, yeast and organelles in cellular lysates to zebra fish cells, lymphoid tissues, human tumor material and numerous cell lines. These services support NIH funded studies involving cancer, immunology, cell biology, drug development, drug delivery and public health. With the current instrumentation we are no longer able to provide state of the art cell sorting technology that is sought by many investigators which in turn impedes their ability to address scientific and healthcare related issues proposed in their various grants.

Public Health Relevance

This request provides state of the art cell sorting instrumentation to support investigators active in various health and scientific related area of research. These investigators are recipients of peer reviewed funding from the NIH and NCI addressing a wide range of health care and scientific questions. To achieve success, many of these studies require the ability to isolate (sort) unique cells from mixed populations which the investigator will use to answer questions and test hypothesis proposed in their funding application.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Biomedical Research Support Shared Instrumentation Grants (S10)
Project #
1S10RR026802-01
Application #
7793689
Study Section
Special Emphasis Panel (ZRG1-CB-J (30))
Program Officer
Levy, Abraham
Project Start
2010-01-26
Project End
2011-01-25
Budget Start
2010-01-26
Budget End
2011-01-25
Support Year
1
Fiscal Year
2010
Total Cost
$499,950
Indirect Cost
Name
University of Utah
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Guo, Jingtao; Grow, Edward J; Mlcochova, Hana et al. (2018) The adult human testis transcriptional cell atlas. Cell Res 28:1141-1157
Trott, Daniel W; Henson, Grant D; Ho, Mi H T et al. (2018) Age-related arterial immune cell infiltration in mice is attenuated by caloric restriction or voluntary exercise. Exp Gerontol 109:99-107
Burch, Joseph S; Marcero, Jason R; Maschek, John Alan et al. (2018) Glutamine via ?-ketoglutarate dehydrogenase provides succinyl-CoA for heme synthesis during erythropoiesis. Blood 132:987-998
Camolotto, Soledad A; Pattabiraman, Shrivatsav; Mosbruger, Timothy L et al. (2018) FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer. Elife 7:
De, Shrutokirti; Van Deren, Donn; Peden, Eric et al. (2018) Two distinct ontogenies confer heterogeneity to mouse brain microglia. Development 145:
Than, Hein; Qiao, Yi; Huang, Xiaomeng et al. (2018) Ongoing clonal evolution in chronic myelomonocytic leukemia on hypomethylating agents: a computational perspective. Leukemia 32:2049-2054
Whiteside, Sarah K; Snook, Jeremy P; Ma, Ying et al. (2018) IL-10 Deficiency Reveals a Role for TLR2-Dependent Bystander Activation of T Cells in Lyme Arthritis. J Immunol 200:1457-1470
Brady, Samuel W; McQuerry, Jasmine A; Qiao, Yi et al. (2017) Combating subclonal evolution of resistant cancer phenotypes. Nat Commun 8:1231
Soto, Raymond; Petersen, Charisse; Novis, Camille L et al. (2017) Microbiota promotes systemic T-cell survival through suppression of an apoptotic factor. Proc Natl Acad Sci U S A 114:5497-5502
Libbey, Jane E; Cusick, Matthew F; Doty, Daniel J et al. (2017) Complement Components Are Expressed by Infiltrating Macrophages/Activated Microglia Early Following Viral Infection. Viral Immunol 30:304-314

Showing the most recent 10 out of 18 publications